Keytruda Injection

MOQ1

Brand NameKeytruda Injection

Salt CompositionPembrolizumab

Dosage FormConcentrate / solution for infusion

Origin of MedicineINDIA

IngredientsKeytruda Injection is used in the treatment of melanoma, non-small cell lung cancer, head and neck cancer, and cervical cancer.Keytruda Injection is given as an infusion into the vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.Some common side effects of this medicine include rash, fatigue, fever, nausea and muscle pain. Some serious side effects which may occur during infusion include chills or shaking, itching, rash, flushing, difficulty breathing and dizziness. Hence, your doctor will check you timely after infusion for allergic reaction.Before taking it, tell your doctor if you have lung disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Physical FormLiquid

MOQ10 Vial/Vials

Payment TermsCash in Advance (CID)

Supply Ability5000 Per Month

Delivery Time10-12 Days

MOQ1 Vial/Vials

Pacakaging (Quantity Per Box)1 Vial per Box

Dosage FormLiquid

Packaging TypeVials in Boxes

Origin of MedicineIndia

Life Span3 years

Drug TypeInjection

MOQ2 Box/Boxes

Origin of Medicineunited state

Dosage Forminjection

Pacakaging (Quantity Per Box)box

Drug TypeInjection

Ingredients100mg of pembrolizumab in 4ml of solution

Physical FormLiquid